See more : ACCO Brands Corporation (ACCO) Income Statement Analysis – Financial Results
Complete financial analysis of Eastwood Bio-Medical Canada Inc. (EBM.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Eastwood Bio-Medical Canada Inc., a leading company in the Food Distribution industry within the Consumer Defensive sector.
- Yao I Fabric Co., Ltd. (4430.TWO) Income Statement Analysis – Financial Results
- Fujipream Corporation (4237.T) Income Statement Analysis – Financial Results
- China Oriental Group Company Limited (CUGCF) Income Statement Analysis – Financial Results
- Grainger plc (GRI.L) Income Statement Analysis – Financial Results
- CSC Financial Co., Ltd. (6066.HK) Income Statement Analysis – Financial Results
Eastwood Bio-Medical Canada Inc. (EBM.V)
About Eastwood Bio-Medical Canada Inc.
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 867.94K | 1.30M | 981.05K | 718.34K | 1.29M | 743.97K | 479.73K | 463.93K | 1.19M | 461.51K | 580.32K |
| Cost of Revenue | 427.42K | 397.02K | 522.68K | 505.03K | 727.81K | 361.30K | 274.49K | 263.45K | 816.51K | 217.45K | 172.03K |
| Gross Profit | 440.51K | 902.74K | 458.37K | 213.31K | 565.09K | 382.68K | 205.24K | 200.48K | 369.58K | 244.07K | 408.29K |
| Gross Profit Ratio | 50.75% | 69.45% | 46.72% | 29.69% | 43.71% | 51.44% | 42.78% | 43.21% | 31.16% | 52.88% | 70.36% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 666.73K | 922.53K | 951.85K | 1.06M | 1.07M | 746.48K | 686.39K | 666.86K | 598.37K | 623.91K | 508.43K |
| Selling & Marketing | 3.31K | 2.70K | 16.48K | 33.86K | 29.76K | 176.51K | 105.05K | 41.11K | 51.83K | 120.63K | 30.43K |
| SG&A | 946.55K | 925.24K | 968.33K | 1.09M | 1.10M | 922.99K | 791.44K | 707.97K | 650.20K | 744.54K | 538.87K |
| Other Expenses | 0.00 | 106.85K | 85.89K | -32.91K | 46.00K | 1.99K | 92.45K | 46.12K | 29.84K | 2.24K | 7.89K |
| Operating Expenses | 946.55K | 1.03M | 1.05M | 1.06M | 1.14M | 948.60K | 791.44K | 707.97K | 650.20K | 748.70K | 551.92K |
| Cost & Expenses | 1.37M | 1.43M | 1.58M | 1.56M | 1.87M | 1.31M | 1.07M | 971.43K | 1.47M | 966.15K | 723.95K |
| Interest Income | 0.00 | 0.00 | 0.00 | 1.37K | 16.41K | 78.44K | 93.83K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 28.16K | 10.71K | 2.79K | 2.37K | 5.32K | 77.13K | 1.35K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 107.85K | 106.85K | 105.30K | 105.74K | 46.00K | 25.61K | -3.42K | 6.03K | 15.53K | 15.96K | 0.00 |
| EBITDA | -410.58K | -32.33K | -495.50K | -744.32K | -526.01K | -540.32K | -586.21K | -501.46K | -258.54K | -504.64K | -143.62K |
| EBITDA Ratio | -47.31% | -1.69% | -49.50% | -102.03% | -40.05% | -22.20% | -123.34% | -108.09% | -23.00% | -106.20% | -24.75% |
| Operating Income | -506.04K | -128.76K | -590.90K | -838.66K | -563.79K | -565.93K | -588.27K | -507.50K | -288.38K | -506.07K | -143.62K |
| Operating Income Ratio | -58.30% | -9.91% | -60.23% | -116.75% | -43.61% | -76.07% | -122.63% | -109.39% | -24.31% | -109.66% | -24.75% |
| Total Other Income/Expenses | -40.56K | -21.12K | -12.70K | -13.78K | -94.00 | -296.05K | 98.65K | 39.02K | 21.05K | -13.02K | 4.34K |
| Income Before Tax | -546.60K | -149.88K | -603.59K | -852.43K | -577.33K | -861.98K | -489.62K | -468.48K | -260.38K | -519.10K | -139.28K |
| Income Before Tax Ratio | -62.98% | -11.53% | -61.53% | -118.67% | -44.65% | -115.86% | -102.06% | -100.98% | -21.95% | -112.48% | -24.00% |
| Income Tax Expense | 0.00 | 10.71K | 7.74K | 7.60K | 2.35K | -218.92K | -713.00 | 1.07K | -5.93K | 741.00 | 0.00 |
| Net Income | -546.60K | -160.58K | -611.34K | -860.03K | -579.68K | -861.98K | -489.62K | -468.48K | -260.38K | -519.10K | -139.28K |
| Net Income Ratio | -62.98% | -12.35% | -62.31% | -119.73% | -44.84% | -115.86% | -102.06% | -100.98% | -21.95% | -112.48% | -24.00% |
| EPS | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M | 67.50M | 67.36M | 67.36M | 51.02M | 48.00M |
| Weighted Avg Shares Out (Dil) | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M | 67.50M | 67.36M | 67.36M | 51.02M | 48.00M |
Source: https://incomestatements.info
Category: Stock Reports